Asthma in the US

Baltimore vs Atlanta
Prepared by
Bosede Adedire, Christina Ikome, Angela Long, &
Evangeline Okechukwu
Coppin State University
February 28, 2013



Asthma Overview
Burden of asthma in the US as a
Asthma mode of treatment
CDC data extract for asthma (2000-2010) for
Baltimore City & Atlanta
US Census data for Baltimore City &
Atlanta (2000-2010)
Calculation of morbidity rate per 100,000 for each

Graphical representation of result

Asthma Overview
 Asthma is one of the main health care problems seen in the western world that is increasing in prevalence.
 Asthma has been characterized as a complex interaction of airway obstruction, bronchial hyper responsiveness with
underlying inflammation.

 Signs and symptoms of an asthma attack could include expiratory wheezing, nonproductive coughing, shortness of breath
pain, chest tightness, prolonged expiration, tachycardia, dyspnea and tachypnea.
 Asthma affects all ages and about half of all cases are identified in early childhood and another 30% being identified
before 40 years old.

Burden of Asthma
on the US
 According to the U. S Census bureau, asthma affects more than 22
million people in the United States and has become a major global
health problem affecting more than 300 million people worldwide
 The burden of asthma on the economy is not far-fetched, from
monetary loss due to rising hospitalization to increase number of
asthma prevalence.
 Treatment and research has not been able to find a cure or means to
prevent asthma incidence.
 Asthma cost in the US grew from about $53billion in 2002 to about
$56 billion in 2007, about a 6% increase

Asthma mode of treatment
 The National Asthma Education and Prevention Program
(NAEPP) have developed classification systems intended
for use in directing asthma treatment
 Two categories for management and treatment of asthma:
control of factors contributing to asthma severity and
pharmacological treatment.
 Measures to control factors contributing to asthma severity
are aimed at prevention of exposure to irritants and factors
that increase asthma symptoms and precipitate asthma

Asthma mode of treatment

 Asthma pharmacological treatment includes the use of
medication for long-term management and short-term
 The short-term relief medication include: albuterol,
bitolterol, pirbuterol, terbuterline. which are administered
by inhalation.
 Long-term treatments of asthma are the use of antiinflammatory medications: these are long acting
bronchodilators and leukotriene modifiers.

CDC & US Census Extract
Graphical Representation: figure 1

Data source:


CDC & US Census Extract
Graphical Representation: figure 2

Data source:


CDC’s national asthma control program. (2013). Retrieved from
McCance, K., Huether, S., Brashers, V., & Rote, N. (2010). Pathophysiology: The
Biologic Basis for Disease in Adults and Children (6th ed.). Missouri: Mosby Inc.
Moorman, J., Akinbami, L., & Bailey, C. (2012). National surveillance of asthma:
United States, 2001-2010. Retrieved from
National Asthma Education and Prevention Program. (2009). Asthma comprehensive treatment
Management. Retrieved from:
Porth, C. & Matfin, G. (2009). Pathophysiology: Concepts of altered health states
(8th ed.). Philadelphia: J.B. Lippincott-Raven.

Patrawalla, P., Kazeros, A., Rogers, L., Shao, Y., Liu, M., Fernandez-Beros, M., Reibman, J. (2012). Application of the as
algorithm from the severe asthma research program to an urban population.
PLOS One, 7(9), 1-7.

Qamar, N., Pappalardo, A., Arora, V., & Press, V. (2011, March 6). Patient-centered care and its effect on outcomes in
of asthma. Patient Related Outcome Measures, 2(2), 81-109.

Ruggeri, I., Bragato, D., Colombo, G., Valla, E., & Matteo, S. (2012). Cost and appropriateness of treating asthma wit
drugs in local health care units in Italy. Clinico economics and Outcomes Research, 4(4), 375-382.
United States Census Bureau. (2012). Asthma prevalence and incidence nationwide
Retrieved from